igfbp4 standards (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
igfbp4 standards
Igfbp4 Standards, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+igfbp+4/Recombinant+Human+IGFBP-4+Protein%2C+CF/pm40158446-82-8-10
Average 93 stars, based on 15 article reviews
Igfbp4 Standards, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+igfbp+4/Recombinant+Human+IGFBP-4+Protein%2C+CF/pm40158446-82-8-10
Average 93 stars, based on 15 article reviews
igfbp4 standards - by Bioz Stars,
2026-09
93/100 stars
Images
1) Product Images from "The special phenotypic characteristics of Dummerstorf superfertile mouse lines could depend on the expression levels of IGF-axis genes."
Article Title: The special phenotypic characteristics of Dummerstorf superfertile mouse lines could depend on the expression levels of IGF-axis genes.
Journal: Reproductive biology
doi: 10.1016/j.repbio.2025.101012
Figure Legend Snippet: Fig. 2. Expression levels of the igf1 (A), igf1r (B), HSF-1 (C), igfbp2 (D), igfbp3 (E), igfbp4 (F), insr (G), lepr (H) and lif (I) genes in uterine samples from the FL1 (red) and FL2 (green) lines compared to those from the ctrl (blue) lines. The data are presented as the mean ± SEM (standard error of the mean) and were considered significant if p < 0.05 (Bonferroni posttest: * p < 0.05; ** p < 0.01; *** p < 0.005).
Techniques Used: Expressing, IF-P
Figure Legend Snippet: Fig. 4. Expression levels of the igf1 (A), hsf1 (B), igfbp2 (C), igfbp3 (D) and igfbp4 (E) genes in follicle samples from the FL1 (red) and FL2 (green) lines compared to those from the ctrl (blue) line. The data are presented as the mean ± SEM (standard error of the mean) and were considered significant if p < 0.05 (Bonferroni posttest: * p < 0.05; ** p < 0.01; *** p < 0.005).
Techniques Used: Expressing, IF-P
Figure Legend Snippet: Fig. 3. Quantity of IGFBP2 (A), IGFBP3 (B) and IGFBP4 (C) binding to the IGF2 protein in uterus samples from the FL1 (red) and FL2 (green) lines compared to those from the ctrl (blue) line. This quantity has been measured using the enhanced chemiluminescence method, eliminating the background (Arbitrary Unit, AU). The data are presented as the mean ± SEM (standard error of the mean) and were considered significant if p < 0.05 (Bonferroni posttest: * p < 0.05; ** p < 0.01; *** p < 0.005).
Techniques Used: Binding Assay, IF-P
Figure Legend Snippet: Fig. 6. Expression levels of igfbp2 (A), igfbp3 (B) and igfbp4 (C) in liver samples from the FL1 (red) and FL2 (green) lines compared to those from the ctrl (blue) line. The data are presented as the mean ± SEM (standard error of the mean) and were considered significant if p < 0.05 (Bonferroni posttest: * p < 0.05; ** p < 0.01; *** p < 0.005). The outliers were analyzed by the ROUT method using GraphPad and excluded.
Techniques Used: Expressing, IF-P
Related Articles
Control:Article Title: Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity Article Snippet: .. Varying doses of an irrelevant control IgG2a antibody (BioXCell) or PAPP-A mAb 1/41 were added 1 h prior to the addition of recombinant human IGF-I (50 ng/ml, R&D Systems), or IGF-I and Article Title: Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity. Article Snippet: .. Varying doses of an irrelevant control IgG2a antibody (BioXCell) or PAPP-A mAb 1/41 were added 1 h prior to the addition of recombinant human IGF-I (50 ng/ml, R&D Systems), or IGF-I and Recombinant:Article Title: Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity Article Snippet: .. Varying doses of an irrelevant control IgG2a antibody (BioXCell) or PAPP-A mAb 1/41 were added 1 h prior to the addition of recombinant human IGF-I (50 ng/ml, R&D Systems), or IGF-I and Article Title: Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity. Article Snippet: .. Varying doses of an irrelevant control IgG2a antibody (BioXCell) or PAPP-A mAb 1/41 were added 1 h prior to the addition of recombinant human IGF-I (50 ng/ml, R&D Systems), or IGF-I and |
